Company / EPS (Diluted)
Medtronic EPS (Diluted) History
FY2017-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$2.76
FY2026
5-year range
$2.66 / $3.73
FY2022-FY2026
Trend
-2.1%
vs FY2025
Sector context
#49 of 159
Health Care
What the data says
At $2.76, Medtronic's eps (diluted) ranks #49 of 159 in the Health Care sector. EPS (Diluted) has fluctuated over the past 10 years, ranging from $2.27 in FY2020 to $3.73 in FY2024.
Based on SEC 10-K filings.
2.76 in FY2026 with a 5-year CAGR of -4.1%.
Declined from $3.73 to $2.76 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- +1.2%
- 5-Year CAGR
- -4.1%
- 10-Year CAGR
- -
Sector benchmark
#49 of 159 in Health CareTop 31% of 159This company $2.76 Sector average $1.56
▼
+77.3% above sector average
Key checks
Key Insights
- In FY2026, eps (diluted) decreased 2.1% year-over-year.
- Ranks #49 out of 159 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2024.
- Lowest eps (diluted) in the period was in FY2020.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2026 | $2.76 | -2.1% |
| FY2025 | $2.82 | -24.4% |
| FY2024 | $3.73 | +40.2% |
| FY2023 | $2.66 | -24.9% |
| FY2022 | $3.54 | +3.8% |
| FY2021 | $3.41 | +50.2% |
| FY2020 | $2.27 | -21.5% |
| FY2019 | $2.89 | +16.5% |
| FY2018 | $2.48 | +2.9% |
| FY2017 | $2.41 | -20.2% |
As of FY2026 · SEC 10-K · Updated Jun 30, 2026